Close Menu

This article has been updated to include information from Foundation Medicine's earnings call.

NEW YORK (GenomeWeb) – Foundation Medicine reported a 70 percent increase in fourth quarter revenues after the close of market Wednesday, driven by both its clinical testing and biopharma business. The results are in line with the company's pre-announcement of its earnings in January.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.